Leukotriene receptor antagonists drugs

What are Leukotriene modifiers? Leukotriene-receptor antagonists, such as montelukast and zafirlukast, prevent leukotrienes from binding to their receptors.

Leukotriene receptor antagonists (also known as leukotriene modifiers) are drugs that block the action of leukotrienes by preventing their

drugs: Montelukast (leukotriene receptor antagonist) and Bilastine (antihistamine). Montelukast belongs to the class of leukotriene receptor antagonists

Leukotriene antagonists, also known as antileukotrienes, are drugs that inhibit leukotrienes. They include: Leukotriene receptor antagonists: montelukast

Drugs that modify the production or activity of leukotriene are known as leukotriene inhibitors, leukotriene receptor antagonists

Leukotriene modifiers are also known as leukotriene receptor antagonists, or leukotriene antagonists. Leukotriene modifiers are a class of prescription drugs, and each drug in the class is approved by the U.S. Food and Drug Administration (FDA). Leukotriene receptor antagonists can be used to prevent breathing problems due to allergies, asthma

Leukotriene receptor antagonists (also known as leukotriene modifiers) are drugs that block the action of leukotrienes by preventing their

Leukotriene antagonists, also known as antileukotrienes, are drugs that inhibit leukotrienes. They include: Leukotriene receptor antagonists: montelukast

Leukotriene receptor antagonists. In Meyler's Side Effects of Drugs (Sixteenth Edition), 2024. General information. The leukotriene receptor antagonists are antagonists of cysteinyl leukotrienes at CysLT 1 receptors and include zafirlukast, montelukast, and pranlukast.